Literature DB >> 19182153

Recovery of vision after adjuvant thalidomide in a child with tuberculous meningitis and acute lymphoblastic leukemia.

Daniela Cristina Stefan1, Savvas Andronikou, Nicola Freeman, Johan Schoeman.   

Abstract

A 7-year-old child, on maintenance chemotherapy for acute lymphoblastic leukemia, developed tuberculous meningitis complicated by progressive basal meningeal inflammation and abscess formation, in spite of adequate tuberculosis treatment and adjunctive corticosteriod therapy. The child became blind as a result of involvement of the optic chiasm. After 2 months of adjunctive thalidomide therapy, the child regained vision and cranial magnetic resonance imaging showed marked reduction of the inflammatory changes previously demonstrated. Progression of intracranial tuberculous infection, in spite of a treatment that is generally considered to be adequate, is well recognized. Previous reports of a possible beneficiary role of thalidomide in these cases support an immunological basis. The present case suggests a role for thalidomide in the treatment of blindness due to involvement of the optic chiasm in progressive basal tuberculous meningitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19182153     DOI: 10.1177/0883073808322329

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  4 in total

1.  Inflammatory bowel disease in Chinese children: A retrospective analysis of 49 cases.

Authors:  Ying Zhou; Ying Huang
Journal:  Exp Ther Med       Date:  2016-09-28       Impact factor: 2.447

2.  Tubercular Meningitis and Lymphadenitis Mimicking a Relapse of Burkitt's Lymphoma on (18)F-FDG-PET/CT: A Case Report.

Authors:  Halima El Omri; Zsolt Hascsi; Ruba Taha; Lajos Szabados; Hesham El Sabah; Amna Gamiel; Ibrahim Al Hijji
Journal:  Case Rep Oncol       Date:  2015-05-07

3.  Poor prognostic significance of Mycobacterium tuberculosis infection during bortezomib-containing chemotherapy in patients with multiple myeloma.

Authors:  Jae-Sook Ahn; Sung Yoon Rew; Deok-Hwan Yang; Sung-Hoon Jung; Seung-Ji Kang; Mi-Young Kim; Seung-Shin Lee; Yeo-Kyeoung Kim; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Blood Res       Date:  2013-03-25

Review 4.  Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis: Case report and review.

Authors:  Miguel Santin; Cristina Escrich; Carles Majòs; Mariona Llaberia; Maria D Grijota; Imma Grau
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.